SONN RSI Chart
Last 7 days
7.1%
Last 30 days
7.1%
Last 90 days
12.4%
Trailing 12 Months
-71.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 92.7K | 0 | 0 | 0 |
2023 | 198.5K | 173.3K | 147.8K | 129.2K |
2022 | 416.8K | 383.4K | 349.9K | 257.4K |
2021 | 0 | 0 | 483.6K | 450.2K |
2020 | 24.4M | 28.7M | 0 | 0 |
2019 | 28.6M | 28.9M | 28.4M | 30.9M |
2018 | 41.6M | 41.2M | 40.6M | 30.7M |
2017 | 41.6M | 41.4M | 41.1M | 41.4M |
2016 | 37.9M | 40.2M | 41.9M | 41.8M |
2015 | 29.8M | 32.0M | 34.2M | 36.4M |
2014 | 12.2M | 17.4M | 25.4M | 27.6M |
2013 | 7.1M | 7.1M | 6.9M | 8.2M |
2012 | 3.0M | 4.6M | 5.9M | 6.9M |
2011 | 549.3K | 858.4K | 1.2M | 1.5M |
2010 | 0 | 447.4K | 291.9K | 136.3K |
2009 | 0 | 0 | 0 | 603.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Oct 27, 2023 | mohan pankaj | bought | - | - | 34,375 | chairman, president and ceo |
Oct 27, 2023 | rao raghu | bought | - | - | 15,625 | - |
Jun 14, 2023 | dexter susan | bought | 7,000 | 0.7 | 10,000 | chief technical officer |
May 30, 2023 | dyrness albert d. | bought | 10,883 | 0.468 | 23,255 | - |
May 17, 2023 | bhatt nailesh | bought | 5,800 | 0.232 | 25,000 | - |
May 15, 2023 | mohan pankaj | bought | 82,866 | 0.223 | 371,600 | chairman, president and ceo |
Mar 15, 2023 | mohan pankaj | bought | 35,100 | 0.585 | 60,000 | chairman, president and ceo |
Feb 06, 2023 | griffith donald j. | sold (taxes) | -518 | 1.043 | -497 | - |
Feb 06, 2023 | cross john harry iii | sold (taxes) | -2,077 | 1.06 | -1,960 | chief financial officer |
Jan 07, 2023 | cini john k. | back to issuer | - | - | -18,551 | chief scientific officer |
Which funds bought or sold SONN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | MORGAN STANLEY | reduced | -90.16 | -95.00 | 11.00 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 11.00 | 11.00 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 30.04 | 1,421 | 5,065 | -% |
May 15, 2024 | CITADEL ADVISORS LLC | sold off | -100 | -51,238 | - | -% |
May 13, 2024 | RENAISSANCE TECHNOLOGIES LLC | sold off | -100 | -76,000 | - | -% |
May 10, 2024 | BlackRock Inc. | reduced | -12.46 | -67.00 | 967 | -% |
May 10, 2024 | CITIGROUP INC | new | - | 71.00 | 71.00 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | added | 4.76 | 4.00 | 41.00 | -% |
May 10, 2024 | OSAIC HOLDINGS, INC. | sold off | -100 | -78.00 | - | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | 1,767 | 27,390 | -% |
Unveiling Sonnet BioTherapeutics Holdings Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Peers (Alternatives to Sonnet BioTherapeutics Holdings Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
Sonnet BioTherapeutics Holdings Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | -100.0% | - | 18,626 | 37,255 | 36,850 | 36,445 | 37,255 | 62,753 | 62,071 | 95,320 | 5,063,547 | 10,031,773 | 15,000,000 | 1,355,000 | 2,715,030 | 9,653,440 | 10,710,773 | 7,837,588 | 239,633 | 10,098,400 | 10,399,924 | 9,995,516 |
Costs and Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | 7,035,328 | 7,920,004 | 13,886,882 | 13,695,319 | 9,532,462 | 2,136,460 | 10,769,716 | 10,820,269 | 12,376,357 |
Operating Expenses | 198.2% | 3,868,561 | 1,297,497 | 3,637,400 | 3,952,160 | 5,701,213 | 5,649,649 | 7,439,718 | 7,929,297 | 8,305,536 | 6,344,751 | 7,430,510 | - | 3,625,844 | 1,199,435 | 5,858,495 | 6,557,415 | 5,151,483 | 1,415,944 | 5,781,284 | 5,640,614 | 5,586,149 |
S&GA Expenses | -100.0% | - | 653,455 | 1,794,765 | 1,542,689 | 1,884,569 | 1,903,709 | 2,315,790 | 2,280,345 | 1,900,263 | 2,078,885 | 2,392,208 | 2,484,148 | 1,208,374 | 1,060,906 | 1,572,774 | 1,012,290 | 1,338,881 | 454,534 | 1,092,529 | 1,121,666 | 1,193,417 |
R&D Expenses | 236.5% | 2,167,288 | 644,042 | 1,842,635 | 2,409,471 | 3,816,644 | 3,745,940 | 5,123,929 | 5,648,952 | 6,405,273 | 4,265,866 | 5,038,302 | 2,455,822 | 1,302,515 | 1,408,148 | - | 391,914 | - | - | - | - | - |
EBITDA Margin | -39.3% | -181 | -130 | -113 | -97.11 | -84.78 | -65.39 | -48.09 | -43.90 | -40.38 | -37.38 | -34.80 | - | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | - | -3,798 | 162,988 | 222,899 | 162,845 | -11,855 | 208,223 | 654,274 | 630,223 | 629,858 | 635,081 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | -3,676 | 12,513 | 4,803 | 5,829 | 50,581 | 78,137 | -206,366 | -236,798 | -336,197 |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | -1,796,202 | -7,823,008 | -4,286,482 | -3,329,837 | -1,922,528 | -2,485,933 | -1,524,978 | -1,042,598 | -3,018,036 |
EBT Margin | -39.3% | -185 | -133 | -116 | -99.45 | -86.82 | -66.96 | -49.25 | -44.96 | -41.35 | -38.28 | -35.64 | - | - | - | - | - | - | - | - | - | - |
Net Income | 131.3% | 365,425 | -1,168,509 | -3,676,739 | -3,946,742 | -5,667,071 | -5,542,142 | -7,435,341 | -7,877,020 | -8,208,499 | -6,200,981 | -6,952,073 | -11,779,050 | -2,496,747 | -2,469,054 | -4,291,285 | -1,416,059 | -283,680 | -292,047 | -1,318,612 | -805,805 | - |
Net Income Margin | 18.8% | -90.87 | -111 | -127 | -130 | -133 | -112 | -84.93 | -76.27 | -65.93 | -56.21 | -51.66 | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 123.4% | 723,792 | -3,091,737 | -4,559,113 | -6,172,025 | -4,695,534 | -5,915,170 | -6,247,934 | -7,824,682 | -5,608,563 | -8,092,349 | -5,938,127 | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 10.7% | 5,909 | 5,338 | 5,429 | 10,035 | 13,311 | 4,943 | 5,830 | 7,490 | 15,046 | 20,741 | 28,994 | 7,176 | 7,626 | 3,033 | 7,994 | 3,881 | 31,319 | 31,533 | 38,478 | 45,424 | 48,086 |
Current Assets | 13.0% | 5,223 | 4,624 | 4,738 | 9,633 | 13,046 | 4,598 | 5,414 | 7,169 | 14,916 | 20,584 | 28,812 | 6,972 | 7,398 | 2,699 | 7,638 | 3,502 | 1,818 | 1,170 | 40.00 | 1,769 | 1,703 |
Cash Equivalents | -100.0% | - | 3,021 | 2,274 | 7,000 | 11,400 | 1,700 | 3,053 | 5,225 | 13,636 | 19,400 | 27,622 | 6,038 | 6,739 | 2,348 | 7,350 | 3,107 | 549 | 501 | 36.00 | 579 | 562 |
Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 272 | 287 | 354 | 421 | 425 |
Net PPE | -10.6% | 27.00 | 30.00 | 33.00 | 37.00 | 40.00 | 43.00 | 46.00 | 49.00 | 53.00 | 56.00 | 59.00 | 59.00 | 62.00 | 65.00 | 68.00 | 71.00 | 5,325 | 5,630 | 8,160 | 9,012 | 10,157 |
Goodwill | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8,513 | 8,568 | 10,499 | 11,275 | 11,313 |
Liabilities | 3.2% | 2,855 | 2,765 | 5,655 | 6,616 | 7,943 | 8,480 | 8,369 | 6,725 | 6,513 | 4,350 | 6,734 | 5,807 | 5,603 | 5,520 | 4,974 | 3,501 | 34,274 | 34,685 | 36,592 | 38,500 | 41,123 |
Current Liabilities | 4.2% | 2,765 | 2,654 | 5,525 | 6,466 | 7,774 | 8,293 | 8,165 | 6,505 | 6,513 | 4,345 | 6,703 | 5,752 | 5,398 | 5,292 | 4,724 | 3,230 | 18,205 | 18,095 | 2,885 | 19,880 | 21,975 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6,348 | 6,631 | 6,682 | 6,620 | 6,772 |
Shareholder's Equity | 18.7% | 3,054 | 2,572 | -225 | 3,418 | 5,369 | -3,537 | -2,538 | 764 | 8,533 | 16,391 | 22,260 | 1,369 | 2,022 | - | 3,020 | 380 | - | - | 5,133 | 6,924 | 6,963 |
Retained Earnings | 0.3% | -111,046 | -111,412 | -110,243 | -106,567 | -102,620 | -96,953 | -91,411 | -83,975 | -76,098 | -67,890 | -61,689 | -54,737 | -48,621 | -42,582 | -36,705 | -29,184 | -77,343 | -75,068 | -12,440 | -62,270 | -59,025 |
Additional Paid-In Capital | 0.1% | 114,101 | 113,984 | 110,018 | 109,982 | 107,987 | 93,415 | 88,872 | 84,734 | 84,626 | 84,275 | 83,949 | 56,103 | 50,642 | 40,094 | 39,724 | 29,564 | 73,471 | 71,506 | 9,594 | 71,210 | 65,126 |
Shares Outstanding | 1.4% | 3,112 | 3,070 | 1,750 | 1,745 | 932 | 314 | 252 | 197 | 196 | 196 | 196 | 73.00 | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 585 | 456 | 485 | 910 | 1,027 |
Float | - | - | - | - | - | 7,300 | - | - | - | 22,100 | - | - | - | 45,019 | - | - | - | 5,713 | - | - | 4,300 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 123.4% | 724 | -3,091 | -4,559 | -6,172 | -4,695 | -5,915 | -6,247 | -7,824 | -5,608 | -8,092 | -5,938 | -5,844 | -5,787 | -4,981 | -5,542 | -6,439 | -1,905 | -1,807 | -1,770 | 293 | -646 |
Share Based Compensation | 20.8% | 60.00 | 50.00 | 50.00 | 50.00 | 57.00 | 92.00 | 86.00 | 108 | 351 | 332 | 318 | 318 | 370 | 370 | - | - | 28.00 | 9.00 | 7.00 | 10.00 | 101 |
Cashflow From Investing | - | - | - | -170 | -12.00 | - | - | 62.00 | -586 | -165 | -120 | - | - | - | - | - | -22.82 | -19.71 | -21.75 | 2,930 | -183 | -18.79 |
Cashflow From Financing | -98.9% | 41.00 | 3,839 | -17.70 | 1,815 | 14,646 | 4,563 | - | - | - | - | 27,526 | 5,144 | 10,178 | -20.12 | 9,786 | 8,947 | 2,007 | 2,684 | 244 | -92.95 | 597 |
Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||||
Collaboration revenue | $ 36,445 | $ 18,626 | $ 73,700 | |
Operating expenses: | ||||
Research and development | 2,167,288 | 3,816,644 | 2,811,330 | 7,562,584 |
General and administrative | 1,701,273 | 1,884,569 | 2,354,728 | 3,788,278 |
Total operating expenses | 3,868,561 | 5,701,213 | 5,166,058 | 11,350,862 |
Loss from operations | (3,868,561) | (5,664,768) | (5,147,432) | (11,277,162) |
Other income | 4,327,946 | 4,327,946 | ||
Foreign exchange (loss) gain | (93,960) | (2,303) | 16,402 | 67,949 |
Net income (loss) | $ 365,425 | $ (5,667,071) | $ (803,084) | $ (11,209,213) |
Per share information: | ||||
Net income (loss) per share, basic | $ 0.08 | $ (7.55) | $ (0.19) | $ (21.14) |
Weighted average shares outstanding, basic | 4,617,665 | 750,582 | 4,205,469 | 530,131 |
Net income (loss) per share, diluted | $ 0.07 | $ (7.55) | $ (0.19) | $ (21.14) |
Weighted average shares outstanding, diluted | 4,885,845 | 750,582 | 4,205,469 | 530,131 |
Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2024 | Sep. 30, 2023 |
---|---|---|
Current assets: | ||
Cash | $ 3,786,184 | $ 2,274,259 |
Prepaid expenses and other current assets | 1,058,836 | 1,677,396 |
Incentive tax receivable | 377,962 | 786,574 |
Total current assets | 5,222,982 | 4,738,229 |
Property and equipment, net | 26,944 | 33,366 |
Operating lease right-of-use asset | 159,641 | 193,689 |
Deferred offering costs | 15,000 | 49,988 |
Other assets | 484,842 | 414,206 |
Total assets | 5,909,409 | 5,429,478 |
Current liabilities: | ||
Accounts payable | 1,752,444 | 2,201,999 |
Accrued expenses and other current liabilities | 933,747 | 3,230,922 |
Current portion of operating lease liability | 78,493 | 73,048 |
Deferred income | 18,626 | |
Total current liabilities | 2,764,684 | 5,524,595 |
Operating lease liability, net of current portion | 90,446 | 130,863 |
Total liabilities | 2,855,130 | 5,655,458 |
Commitments and contingencies (Note 4) | ||
Stockholders’ equity (deficit): | ||
Common stock, $0.0001 par value: 125,000,000 shares authorized; 3,112,401 and 1,750,426 issued and outstanding at March 31, 2024 and September 30, 2023, respectively | 311 | 175 |
Additional paid-in capital | 114,100,805 | 110,017,598 |
Accumulated deficit | (111,046,837) | (110,243,753) |
Total stockholders’ equity (deficit) | 3,054,279 | (225,980) |
Total liabilities and stockholders’ equity (deficit) | $ 5,909,409 | $ 5,429,478 |